BetterBirth: A Trial of the WHO Safe Childbirth Checklist Program

NCT02148952 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 157689

Last updated 2024-06-26

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to measure the impact of a checklist-based childbirth safety program (the WHO Safe Childbirth Checklist Program) on reduction of severe maternal, fetal, and newborn harm in institutional deliveries in north India.

Conditions

  • Maternal Death
  • Maternal Morbidity
  • Stillbirth
  • Neonatal Death

Interventions

BEHAVIORAL

WHO Safe Childbirth Checklist Program

The IHF group will receive the WHO Safe Childbirth Checklist Program designed to maximize likelihood of effective and sustained uptake of the program by birth attendants in the designated facilities. The program includes three key implementation steps that involve: engagement of leadership and clinicians at the state, district, and local levels, a formal launch to introduce the Checklist, and support through peer coaching and data feedback. The intervention facilities will also receive a standardized maternity register to ensure appropriate data collection.

Sponsors & Collaborators

  • World Health Organization

    collaborator OTHER
  • Population Services International

    collaborator OTHER
  • Jawaharlal Nehru Medical College

    collaborator OTHER
  • Community Empowerment Lab

    collaborator OTHER
  • Brigham and Women's Hospital

    collaborator OTHER
  • Bill and Melinda Gates Foundation

    collaborator OTHER
  • MacArthur Foundation

    collaborator OTHER
  • Harvard School of Public Health (HSPH)

    lead OTHER

Principal Investigators

  • Atul Gawande, MD, MPH · Harvard School of Public Health (HSPH)

  • Vishwajeet Kumar, MBBS, MPH · Community Empowerment Lab

  • Bhala Kodkany, MBBS · Jawarhlal Nehru Medical College

  • Katherine Semrau, PhD · Harvard Medical School/ Ariadne Labs

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-11-30
Primary Completion
2017-01-20
Completion
2017-07-18

Countries

  • India

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02148952 on ClinicalTrials.gov